5′‐Deoxy‐5′‐fluorothymidine (5′‐fluorothymidine) inhibits the DNA synthesis of cells of the Ehrlich ascites carcinoma of the mouse (carcinoma) in vitro, as estimated by the incorporation of radioactive phosphate. About 90 or 50% inhibition is obtained at concentrations of 1 mM or 70 μM, respectively. The synthesis of neither RNA nor protein is inhibited by 5′‐fluorothymidine. The inhibition of DNA synthesis cannot be reversed by thymidine. In cell‐free extracts obtained from carcinoma cells, 5′‐fluorothymidine strongly inhibits the phosphorylation of thymidine‐5′‐monophosphate, but hardly at all that of thymidine. A large accumulation of thymidine‐5′‐monophosphate is found among the phosphorylation products derived from thymidine in the presence of 5′‐fluorothymidine. Thus, 5′‐fluorothymidine acts as inhibitory analogue of thymidine‐5′‐monophosphate in the thymidine‐5′‐monophosphate kinase reaction. The inhibition of thymidine‐5′‐monophosphate kinase is competitive. The affinity of the analogue for the enzyme is about three times higher than that of the substrate. The enzyme is also inhibited by thymidine, but its inhibitory activity is only one tenth that of 5′‐fluorothymidine. 5′‐fluorothymidine provides protection of the enzyme against inactivation brought about by incubation in the absence of the substrate. 5′‐fluorothymidine is degraded by pyrimidine phosphorylases at a rate of only one sixth that of thymidine. 5′‐fluorothymidine inhibits the multiplication of carcinoma cells in vitro either completely or by 60% at concentrations of 100 or 10 μM, respectively. The increase in fermentation, normally associated with this cell multiplication, is much less influenced by 5′‐fluorothymidine. Thus, the effect of 5′‐fluorothymidine is primarily seen in cell division, but to a less extent in the development of cytoplasmic processes (similar to unbalanced growth). Since 5′‐fluorothymidine cannot be phosphorylated at C‐5′ it must be assumed to act unchanged as such. This is in contrast to the classical base, or nucleoside, analogues, which, for inhibitory activity, have to be transferred intracellularly into the nucleotides (lethal synthesis). The independence of 5′‐fluorothymidine of lethal synthesis should be of advantage with regard to resistance problems for a possible use of this compound in cancer chemotherapy.